Actively Recruiting
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
Led by Central Hospital, Nancy, France · Updated on 2023-06-05
200
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure. The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.
CONDITIONS
Official Title
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized for acute heart failure.
- Patients with reduced ejection fraction (Ejection Fraction <40%) or (40% 64 Ejection Fraction < 50).
- Patients considered clinically ready for discharge from hospitalization for acute heart failure.
- Age 18 years or older.
- Patients who have received complete information about the study design and have signed informed consent.
- Patients affiliated with or beneficiaries of a social security scheme.
You will not qualify if you...
- Comorbidity with life expectancy of 3 months or less.
- Dialysis patients (peritoneal or hemodialysis) or patients with glomerular filtration rate <15 ml/min/m2 at inclusion.
- History of lobectomy or pneumonectomy lung surgery.
- Severe pulmonary or pleural diseases preventing reliable lung ultrasound imaging, such as severe emphysema, chronic pleurisy, or pulmonary fibrosis.
- Pregnant women, parturient, or nursing mothers.
- Adults under legal protection measures (guardianship, curatorship, safeguard of justice) or unable to give consent.
- Persons deprived of liberty by judicial or administrative decision.
- Persons under psychiatric care according to relevant public health codes.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRU de Nancy
Vandœuvre-lès-Nancy, France, 54500
Actively Recruiting
Research Team
N
Nicolas GIRERD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here